Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Genomic Tree
Genomic Tree
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Genomic Tree
Stock Price
₩16.6 K
2024-10-29
Market Capitalization
₩403.8 B
2024-10-29
Revenue
₩2.4 B
FY, 2024
Genomic Tree Summary
Company Summary
Overview
Genomic Tree ((주)지노믹트리) is a biotechnology company that develops in-vitro molecular diagnostic products. It offers Earlytech, an early detection product for lung, colon, and bladder cancer, AccuraTect, a cancer companion diagnostic product, etc.
Type
Public
Status
Active
Founded
2000
Website
http://genomictree.com/ko/
Cybersecurity rating
Sectors
Healthcare
biotech
genetics
medical diagnostics
Homepage
Linkedin
twitter
Table of Contents
Financials
Competitors
Genomic Tree Financials
Summary Financials
Revenue (Q3, 2025)
₩896.8M
Gross profit (Q3, 2025)
₩320.1M
Net income (Q3, 2025)
(₩2.8B)
Cash (Q3, 2025)
₩16.1B
EBIT (Q3, 2025)
(₩3.3B)
Enterprise value
$389.9B
Competitors and Similar Companies
Veracyte
Healthcare - Public
Yourgene Health
Healthcare - Subsidiary
Ambry Genetics
Healthcare - Subsidiary
Fulgent Genetics
Healthcare - Public
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top